{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:19:41Z","timestamp":1790803181782,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["Lacto-Be 26850"],"award-info":[{"award-number":["Lacto-Be 26850"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1277222N"],"award-info":[{"award-number":["1277222N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12S4222N"],"award-info":[{"award-number":["12S4222N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.xcrm.2023.101371","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T10:38:06Z","timestamp":1705401486000},"page":"101371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9906-5151","authenticated-orcid":false,"given":"Eline","family":"Cauwenberghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilke","family":"De Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Spacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilke","family":"Van Tente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Bastiaenssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Lammertyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Van Hoorenbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9400-6918","authenticated-orcid":false,"given":"Sarah","family":"Lebeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101371_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib2","article-title":"Probiotics for people with cystic fibrosis","volume":"2","author":"Coffey","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.xcrm.2023.101371_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1574-695X.2011.00925.x","article-title":"The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients","volume":"65","author":"Rudkj\u00f8bing","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis","volume":"177","author":"Tunney","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2023.02.004","article-title":"Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del","volume":"22","author":"Lopez","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib6","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3390\/cells10102793","article-title":"Therapeutic approaches for patients with cystic fibrosis not eligible for current CFTR modulators","volume":"10","author":"Fajac","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2023.101371_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib8","article-title":"Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during Pseudomonas Infection","volume":"1","author":"Dugger","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1164\/rccm.201509-1759OC","article-title":"Development of the nasopharyngeal microbiota in infants with cystic fibrosis","volume":"193","author":"Prevaes","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib10","doi-asserted-by":"crossref","first-page":"153ra130","DOI":"10.1126\/scitranslmed.3004458","article-title":"Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis","volume":"4","author":"Blainey","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109798","article-title":"The microbial community of the cystic fibrosis airway is disrupted in early life","volume":"9","author":"Renwick","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101371_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/lary.27454","article-title":"Loss of microbial niche specificity between the upper and lower airways in patients with cystic fibrosis","volume":"129","author":"Pletcher","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.xcrm.2023.101371_bib13","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.1120577109","article-title":"Decade-long bacterial community dynamics in cystic fibrosis airways","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101371_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045001","article-title":"The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations","volume":"7","author":"Fodor","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101371_bib15","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.1038\/srep10241","article-title":"Lung microbiota across age and disease stage in cystic fibrosis","volume":"5","author":"Coburn","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2023.101371_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-020-00810-3","article-title":"Lung function and microbiota diversity in cystic fibrosis","volume":"8","author":"Cuthbertson","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.xcrm.2023.101371_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report","volume":"169","author":"Hoyle","year":"2018","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib18","series-title":"Cystic Fibrosis Foundation Patient Registry 2022 Annual Data Report","year":"2022"},{"key":"10.1016\/j.xcrm.2023.101371_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1186\/s13063-022-07047-5","article-title":"Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b\/2, multicenter, randomized, double-blind, placebo-controlled trial","volume":"23","author":"Tamma","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.xcrm.2023.101371_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2020.07.004","article-title":"Early Life Microbiota and Respiratory Tract Infections","volume":"28","author":"de Steenhuijsen Piters","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101371_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.201104-0655OC","article-title":"Topographical continuity of bacterial populations in the healthy human respiratory tract","volume":"184","author":"Charlson","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02287-16","article-title":"Bacterial topography of the healthy human lower respiratory tract","volume":"8","author":"Dickson","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2023.101371_bib31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/biomedicines11030841","article-title":"Characterization of the lower airways and oral microbiota in healthy young persons in the community","volume":"11","author":"Leitao Filho","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2023.101371_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/2049-2618-1-19","article-title":"Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation","volume":"1","author":"Segal","year":"2013","journal-title":"Microbiome"},{"key":"10.1016\/j.xcrm.2023.101371_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02235-2016","article-title":"Concordance between upper and lower airway microbiota in infants with cystic fibrosis","volume":"49","author":"Prevaes","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2023.101371_bib34","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3389\/fmicb.2020.01463","article-title":"The respiratory microbiome in cystic fibrosis: compartment patterns and clinical relationships in early stage disease","volume":"11","author":"Garcia-Nu\u00f1ez","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006798","article-title":"Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children","volume":"14","author":"Muhlebach","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101371_bib36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/thoraxjnl-2016-209279","article-title":"The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis","volume":"72","author":"Frayman","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.xcrm.2023.101371_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41396-021-01129-z","article-title":"Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways","volume":"16","author":"Widder","year":"2022","journal-title":"ISME J."},{"key":"10.1016\/j.xcrm.2023.101371_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00010-18","article-title":"Translating recent microbiome insights in otitis media into probiotic strategies","volume":"32","author":"van den Broek","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.xcrm.2023.101371_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/gbe\/evw039","article-title":"Comparative genomic analyses of the moraxella catarrhalis serosensitive and seroresistant lineages demonstrate their independent evolution","volume":"8","author":"Earl","year":"2016","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.xcrm.2023.101371_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40168-017-0234-1","article-title":"Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details","volume":"5","author":"Feigelman","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.xcrm.2023.101371_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41479-018-0051-8","article-title":"How low can we go? The implications of low bacterial load in respiratory microbiota studies","volume":"10","author":"Marsh","year":"2018","journal-title":"Pneumonia"},{"key":"10.1016\/j.xcrm.2023.101371_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02372","article-title":"Comparing the healthy nose and nasopharynx microbiota reveals continuity as well as niche-specificity","volume":"8","author":"De Boeck","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcf.2017.08.007","article-title":"16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients","volume":"17","author":"Lucas","year":"2018","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib25","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1513\/AnnalsATS.201702-121OC","article-title":"Association of antibiotics, airway microbiome, and inflammation in infants with cystic fibrosis","volume":"14","author":"Pittman","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.xcrm.2023.101371_bib26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ismej.2014.250","article-title":"Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age","volume":"9","author":"Stearns","year":"2015","journal-title":"ISME J."},{"key":"10.1016\/j.xcrm.2023.101371_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01711-2018","article-title":"Characterising the respiratory microbiome","volume":"53","author":"Watson","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2023.101371_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/cir399","article-title":"Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis","volume":"53","author":"Gangell","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101371_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00069-18","article-title":"Evaluating the information content of shallow shotgun metagenomics","volume":"3","author":"Hillmann","year":"2018","journal-title":"mSystems"},{"key":"10.1016\/j.xcrm.2023.101371_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02863-20","article-title":"Strain-resolved dynamics of the lung microbiome in patients with cystic fibrosis","volume":"12","author":"Dmitrijeva","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2023.101371_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03633-22","article-title":"The cystic fibrosis upper and lower airway metagenome","volume":"11","author":"Pienkowska","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.xcrm.2023.101371_bib43","doi-asserted-by":"crossref","first-page":"598938","DOI":"10.3389\/fcimb.2020.598938","article-title":"The lung microbiome of three young Brazilian patients with cystic fibrosis colonized by fungi","volume":"10","author":"de Almeida","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib44","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3390\/ijms18081654","article-title":"A different microbiome gene repertoire in the airways of cystic fibrosis patients with severe lung disease","volume":"18","author":"Bacci","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2023.101371_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fcimb.2020.00174","article-title":"Longitudinal associations of the cystic fibrosis airway microbiome and volatile metabolites: a case study","volume":"10","author":"Hahn","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/microorganisms8071003","article-title":"Untargeted metagenomic investigation of the airway microbiome of cystic fibrosis patients with moderate-severe lung disease","volume":"8","author":"Bacci","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.xcrm.2023.101371_bib47","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2019.01.091","article-title":"Human and extracellular DNA depletion for metagenomic analysis of complex clinical infection samples yields optimized viable microbiome profiles","volume":"26","author":"Nelson","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101371_bib48","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","article-title":"The cystic fibrosis lung microbiome","volume":"11","author":"Surette","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.xcrm.2023.101371_bib49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcf.2016.01.001","article-title":"Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis","volume":"15","author":"Zampoli","year":"2016","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib50","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1073\/pnas.1107435109","article-title":"Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota","volume":"109","author":"Goddard","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101371_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2500\/ajra.2017.31.4461","article-title":"Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review","volume":"31","author":"M\u00f8ller","year":"2017","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.xcrm.2023.101371_bib52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcf.2015.09.001","article-title":"Diagnostic accuracy and distress associated with oropharyngeal suction in cystic fibrosis","volume":"15","author":"Doumit","year":"2016","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib53","doi-asserted-by":"crossref","first-page":"5047403","DOI":"10.1155\/2017\/5047403","article-title":"Comparison of oropharyngeal microbiota from children with asthma and cystic fibrosis","volume":"2017","author":"Boutin","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.xcrm.2023.101371_bib54","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic fibrosis pulmonary exacerbations attributable to Respiratory Syncytial Virus and Influenza: a population-based study","volume":"64","author":"Somayaji","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101371_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105854","article-title":"Respiratory viral infections in Western Australians with cystic fibrosis","volume":"161","author":"Brestovac","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1542\/peds.2007-3139","article-title":"Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study","volume":"122","author":"Van Ewijk","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.xcrm.2023.101371_bib57","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.12-0954","article-title":"High rhinovirus burden in lower airways of children with cystic fibrosis","volume":"143","author":"Kieninger","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.xcrm.2023.101371_bib58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1526-0542(03)00059-9","article-title":"Respiratory virus infections in cystic fibrosis","volume":"4","author":"Wat","year":"2003","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.xcrm.2023.101371_bib59","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3389\/fimmu.2018.03067","article-title":"Viral-bacterial co-infections in the cystic fibrosis respiratory tract","volume":"9","author":"Kiedrowski","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101371_bib60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1183\/09031936.00202311","article-title":"Viral infections trigger exacerbations of cystic fibrosis in adults and children","volume":"40","author":"Wark","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2023.101371_bib61","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1203\/pdr.0b013e3180332d1c","article-title":"RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells","volume":"61","author":"Van Ewijk","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.xcrm.2023.101371_bib62","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1073\/pnas.1516979113","article-title":"Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity","volume":"113","author":"Hendricks","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101371_bib63","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ppul.22917","article-title":"Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis","volume":"49","author":"Esther","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.xcrm.2023.101371_bib64","doi-asserted-by":"crossref","first-page":"L436","DOI":"10.1152\/ajplung.00097.2007","article-title":"MAPK and heat shock protein 27 activation are associated with respiratory syncytial virus induction of human bronchial epithelial monolayer disruption","volume":"293","author":"Singh","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib65","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.jaci.2017.07.018","article-title":"Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures","volume":"141","author":"Essaidi-Laziosi","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2023.101371_bib66","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1128\/IAI.00789-06","article-title":"Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection","volume":"74","author":"McNamee","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2023.101371_bib67","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/infdis\/jit830","article-title":"Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production","volume":"209","author":"Subramaniam","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101371_bib68","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11046-021-00574-w","article-title":"Emerging Fungal Threats in Cystic Fibrosis","volume":"186","author":"Schwarz","year":"2021","journal-title":"Mycopath"},{"key":"10.1016\/j.xcrm.2023.101371_bib69","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ppul.23302","article-title":"Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis","volume":"50","author":"Gileles-Hillel","year":"2015","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.xcrm.2023.101371_bib70","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jcf.2023.02.003","article-title":"Distinct community structures of the fungal microbiome and respiratory health in adults with cystic fibrosis","volume":"22","author":"Hong","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12890-017-0416-4","article-title":"Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis","volume":"17","author":"Reece","year":"2017","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib72","doi-asserted-by":"crossref","first-page":"e0009421","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of Respiratory Viral and Fungal Coinfections","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.xcrm.2023.101371_bib73","doi-asserted-by":"crossref","first-page":"e36313","DOI":"10.1371\/journal.pone.0036313","article-title":"The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management","volume":"7","author":"Delhaes","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101371_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ppul.20604","article-title":"Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function","volume":"42","author":"Ren","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.xcrm.2023.101371_bib75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/thoraxjnl-2019-213485","article-title":"Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes","volume":"75","author":"Ramsheh","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.xcrm.2023.101371_bib76","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0041-2019","article-title":"Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens","volume":"28","author":"Vandeplassche","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.xcrm.2023.101371_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-017-0265-7","article-title":"The effects of inhaled aztreonam on the cystic fibrosis lung microbiome","volume":"5","author":"Heirali","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.xcrm.2023.101371_bib78","first-page":"148","article-title":"Prescribing an antibiotic? Pair it with probiotics","volume":"62","author":"Rodgers","year":"2013","journal-title":"J.\u00a0Fam. Pract."},{"key":"10.1016\/j.xcrm.2023.101371_bib79","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jhn.12991","article-title":"Probiotic use in adults with cystic fibrosis is common and influenced by gastrointestinal health needs: A cross-sectional survey study","volume":"35","author":"Anderson","year":"2022","journal-title":"J.\u00a0Hum. Nutr. Diet."},{"key":"10.1016\/j.xcrm.2023.101371_bib80","first-page":"410","article-title":"Elexacaftor-Tezacaftor-Ivacaftor: a life-changing triple combination of CFTR modulator drugs for cystic fibrosis","volume":"16","author":"Bacalhau","year":"2023","journal-title":"Pharm. Times"},{"key":"10.1016\/j.xcrm.2023.101371_bib81","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/children10030554","article-title":"Efficacy and safety of Elexacaftor-Tezacaftor-Ivacaftor in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Kapouni","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.xcrm.2023.101371_bib82","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fphar.2023.1158207","article-title":"Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor\u2014Ivacaftor","volume":"14","author":"T\u00fcmmler","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2023.101371_bib83","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2023.101371_bib84","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ppul.26261","article-title":"Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis","volume":"58","author":"Sheikh","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.xcrm.2023.101371_bib85","article-title":"The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant","volume":"61","author":"Burgel","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2023.101371_bib86","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jcf.2022.03.006","article-title":"Global access to affordable CFTR modulator drugs: Time for action!","volume":"21","author":"Zampoli","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist","volume":"133","author":"Nichols","year":"2023","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101371_bib88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1513\/AnnalsATS.201907-493OC","article-title":"Changes in airway microbiome and inflammation with Ivacaftor treatment in patients with cystic fibrosis and the G551D mutation","volume":"17","author":"Harris","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.xcrm.2023.101371_bib89","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00731-2020","article-title":"Lumacaftor\/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients","volume":"7","author":"Neerincx","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.xcrm.2023.101371_bib90","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.xcrm.2023.101371_bib91","doi-asserted-by":"crossref","first-page":"e0314821","DOI":"10.1128\/mbio.03148-21","article-title":"Combining Ivacaftor and intensive antibiotics achieves limited clearance of cystic fibrosis infections","volume":"12","author":"Durfey","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2023.101371_bib92","doi-asserted-by":"crossref","first-page":"e0145422","DOI":"10.1128\/spectrum.01454-22","article-title":"Impact of Elexacaftor\/Tezacaftor\/Ivacaftor therapy on the cystic fibrosis airway microbial metagenome","volume":"10","author":"Pallenberg","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.xcrm.2023.101371_bib93","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcf.2019.07.008","article-title":"The impact of CFTR modulator therapies on CF airway microbiology","volume":"19","author":"Rogers","year":"2020","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib96","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/all.13495","article-title":"Probiotics for the airways: Potential to improve epithelial and immune homeostasis","volume":"73","author":"Martens","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.xcrm.2023.101371_bib97","first-page":"506","article-title":"Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.xcrm.2023.101371_bib98","series-title":"Early Clinical Trials with Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Guidance for Industry","year":"2016"},{"key":"10.1016\/j.xcrm.2023.101371_bib99","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: the importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib100","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/thoraxjnl-2018-211510","article-title":"Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis","volume":"73","author":"Acosta","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.xcrm.2023.101371_bib101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.csbj.2021.12.008","article-title":"Bacterial low-abundant taxa are key determinants of a healthy airway metagenome in the early years of human life","volume":"20","author":"Pust","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2023.101371_bib102","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.3390\/nu12082453","article-title":"The development of high-quality multispecies probiotic formulations: from bench to market","volume":"12","author":"Grumet","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.xcrm.2023.101371_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11030326","article-title":"Lung-directed bacteriotherapy in cystic fibrosis: could it be an option?","volume":"11","author":"Batoni","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.xcrm.2023.101371_bib95","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib132","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.molmed.2021.03.009","article-title":"Topical microbial therapeutics against respiratory viral infections","volume":"27","author":"Spacova","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib103","first-page":"57","article-title":"Lactic Acid Bacteria as Potential Probiotics. Probiotics, Prebiotics Synbiotics Technol","author":"Sadiq","year":"2022","journal-title":"Adv. Towar. Saf. Ind. Appl."},{"key":"10.1016\/j.xcrm.2023.101371_bib104","doi-asserted-by":"crossref","first-page":"102978","DOI":"10.1016\/j.isci.2021.102978","article-title":"The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms","volume":"24","author":"De Boeck","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2023.101371_bib105","doi-asserted-by":"crossref","first-page":"107674","DOI":"10.1016\/j.celrep.2020.107674","article-title":"Lactobacilli Have a Niche in the Human Nose","volume":"31","author":"De Boeck","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101371_bib106","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1038\/s41467-019-13698-x","article-title":"The upper-airway microbiota and loss of asthma control among asthmatic children","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101371_bib107","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2023.101371_bib108","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clnu.2007.01.004","article-title":"Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study","volume":"26","author":"Bruzzese","year":"2007","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.xcrm.2023.101371_bib109","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","article-title":"Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study","volume":"13","author":"del Campo","year":"2014","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib110","first-page":"475","article-title":"The effect of probiotics on fecal calprotectin in patients with cystic fibrosis","volume":"55","author":"Fallahi","year":"2013","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.xcrm.2023.101371_bib111","first-page":"542","article-title":"Lactobacillus casei strain FF as adjunctive treatment to children with cystic fibrosis","volume":"26","author":"Di Benedetto","year":"1998","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.xcrm.2023.101371_bib112","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2023.101371_bib113","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ppul.21138","article-title":"Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study","volume":"45","author":"Weiss","year":"2010","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.xcrm.2023.101371_bib114","first-page":"669","article-title":"Effects of Probiotics on Quality of Life in Children with Cystic Fibrosis; a Randomized Controlled Trial","volume":"23","author":"Jafari","year":"2013","journal-title":"Iran J. Pediatr"},{"key":"10.1016\/j.xcrm.2023.101371_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087796","article-title":"Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: A randomised clinical trial","volume":"9","author":"Bruzzese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101371_bib116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPG.0000000000000187","article-title":"Lactobacillus reuteri ATCC55730 in cystic fibrosis","volume":"58","author":"Di Nardo","year":"2014","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.xcrm.2023.101371_bib117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clnesp.2018.06.008","article-title":"Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas\/CF","volume":"27","author":"Van Biervliet","year":"2018","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.xcrm.2023.101371_bib118","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41430-017-0043-4","article-title":"Effect of synbiotic supplementation in children and adolescents with cystic fibrosis: a randomized controlled clinical trial","volume":"72","author":"De Freitas","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.xcrm.2023.101371_bib119","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2017.10.014","article-title":"Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial","volume":"17","author":"Bruzzese","year":"2018","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12890-022-02078-9","article-title":"Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis","volume":"22","author":"Ray","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.xcrm.2023.101371_bib121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib122","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcf.2016.09.004","article-title":"Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review","volume":"16","author":"Anderson","year":"2017","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.xcrm.2023.101371_bib123","first-page":"32","article-title":"Chronic rhinosinusitis in cystic fibrosis: diagnosis and medical management","volume":"7","author":"Safi","year":"2019","journal-title":"Med. Sci."},{"key":"10.1016\/j.xcrm.2023.101371_bib124","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/lio2.93","article-title":"Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial","volume":"2","author":"M\u00e5rtensson","year":"2017","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"10.1016\/j.xcrm.2023.101371_bib125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fcimb.2020.00440","article-title":"Intranasal application of lactococcus lactis W136 is safe in chronic rhinosinusitis patients with previous sinus surgery","volume":"10","author":"Endam","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101371_bib126","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/1751-7915.13759","article-title":"Lactic acid bacteria as probiotics for the nose?","volume":"14","author":"De Boeck","year":"2021","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101371_bib127","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/1751-7915.14189","article-title":"Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections","volume":"16","author":"Spacova","year":"2023","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101371_bib128","doi-asserted-by":"crossref","first-page":"e0168222","DOI":"10.1128\/spectrum.01682-22","article-title":"Randomized, double-blind, placebo-controlled trial of a throat spray with selected Lactobacilli in COVID-19 outpatients","volume":"10","author":"De Boeck","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.xcrm.2023.101371_bib129","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1016\/j.celrep.2018.08.090","article-title":"Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases","volume":"24","author":"Le Noci","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101371_bib130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thorax-2023-220100","article-title":"A refresh of the top 10 research priorities in cystic fibrosis","volume":"78","author":"Rowbotham","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.xcrm.2023.101371_bib131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature02725","article-title":"Developmental plasticity and human health","volume":"430","author":"Bateson","year":"2004","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123006006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123006006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:29:08Z","timestamp":1767965348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123006006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2666379123006006"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101371","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101371"}}